Sildenafil
Product Images NDC 50436-0034
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50436-0034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Sildenafil 01)
Figure 2 (Sildenafil 02)
Figure 3 (Sildenafil 03)
Figure 4 (Sildenafil 04)
Figure 5 (Sildenafil 05)
Figure 6 (Sildenafil 06)
Chemical Structure (Sildenafil 07)
Figure 7 (Sildenafil 08)
This is a table containing interactions of various drugs with Sildenafil. It includes information on dose adjustments and recommendations for various drugs such as Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Mazlox, Oral Contraceptives, Ritonavir, and Saquinavir. There is also a graphical representation of the change relative to Sildenafil alone, with a solid line indicating where there is no change. Further information is given about the clinical studies of the interaction between Sildenafil and Bosentan.*
Figure 8 (Sildenafil 09)
This is a list of drugs that interact with Acenocoumarol, including Aspirin, Atorvastatin, Bosentan, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, and Saquinavir. The table provides information on the interaction of the drugs with Acenocoumarol, including INR AUC, INR Cmax, BT, Auc, Cmax, and fold change with 90% CI. For some drugs, there is a recommendation for no dose adjustment, while for others, co-administration is not recommended. The text also indicates that sildenafil added to bosentan therapy may not provide any benefit in exercise capacity, and that the effect of ritonavir on sildenafil PK should be considered.*
Figure 9 (Sildenafil 10)
Figure 10 (Sildenafil 11)
The text seems to contain a prescription including the name of a medication "Placobo Sidenatl & Sidonati 20mg TID". Additionally, it includes a table with some medical data such as "Basalino walk distance" and "Etiology". It mentions some conditions such as "WdopathicPAH" and "PHCTD", and "functional capacity el". Not enough context is given for more specific description.*
Figure 11 (Sildenafil 12)
Figure 12 (Sildenafil 13)
This appears to be a graph depicting the mean change from baseline in meters for each treatment at each visit up to week 12. The X-axis shows the weeks of the study (up to week 12) and the Y-axis measures the change from the baseline in meters. Three treatments are shown: Sildenafil ImgTID, Sildenafil 5mg TD, and Sildenafil 20mg TID. The graph includes error bars.*
Logo (Sildenafil 14)
Logo (Sildenafil 15)
Figure A (Sildenafil 16)
Figure B (Sildenafil 17)
Figure C (Sildenafil 18)
Figure D (Sildenafil 19)
Figure E (Sildenafil 20)
Figure F (Sildenafil 21)
Figure G (Sildenafil 22)
Logo (Sildenafil 23)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.